We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
20 hedge funds and large institutions have $6.84M invested in Decoy Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% less ownership
Funds ownership: 0% → 0% (-0%)
26% less funds holding
Funds holding: 27 → 20 (-7)
33% less capital invested
Capital invested by funds: $10.2M → $6.84M (-$3.35M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
20
Holders Change
-7
Holders Change %
-25.93%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$242K |
| 2 |
Two Sigma Advisers
New York
|
+$104K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$69K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$34.5K |
| 5 |
Millennium Management
New York
|
+$34.5K |
